Close

Merck (MRK) Provides Statement Regarding CUBICIN Patent Litigation

November 12, 2015 11:50 AM EST Send to a Friend
Merck (NYSE: MRK), known as MSD outside the United States and Canada, issued the following statement ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login